by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Treatment of fibrosis and pulmonary vascular disease is ripe for improvement. Our featured experts consider recent investigative work, looking forw......READ MORE
by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Clinicians face multiple obstacles and challenges to the early diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), including its simila......READ MORE
by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Connective tissue disease–associated interstitial lung disease (CTD-ILD) represents a nexus of subspecialty interests, where multidisciplinary care......READ MORE
by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Predicting the progression of fibrotic lung disease and pulmonary vascular disease in interstitial lung disease (ILD) historically has been challen......READ MORE
